retatrutide triple hormone receptor agonist retatrutide Original Article: Triple–Hormone-Receptor for Obesity — A Phase 2 Trial https://t.co/jNL1GNnHPT #ADA23 Triple hormone receptor agonist retatrutide

Always consult with your healthcare provider about your specific situation and concerns.

Novo Nordisk has cut its full-year forecast three times in 2025 as GLP-1 growth rates decelerated sharply

Tirzepatide : Also targeting weight loss and glucose control, this medication acts on both GLP-1 and GIP receptors, potentially offering greater efficacy

One of the most pharmacologically relevant features of retatrutide shared with other GLP-1 receptor agonists such as semaglutide and liraglutide is its potential to delay gastric emptying

Its bad enough to deal with the world, but being constantly plagued by my own negative self-talk is soul-destroying

doi:10.1161/atvbaha.110.206425 47